Dabigatran Following Transient Ischemic Attack and Minor Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT02295826
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT02295826
-
- Other papers using this trial's data
- Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02295826. Randomized; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2018-12-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dabigatran Following Transient Ischemic Attack and Minor Stroke
- Acronym
- DATAS II
- Condition
- Transient Ischemic Attack
- Condition
- Minor Ischemic Stroke
- Intervention (Drug)
- Dabigatran
- Intervention (Drug)
- Acetylsalicylic acid
- Lead sponsor
- University of Alberta
Record details
- Record id
cardio:ct-nct02295826- Content hash
01d19ee196b19132efa1fd24674c5d08676cf5ab884a110b8cfe3ffc8762a5ea